TMS Therapy for treatment of drug-resistant depression

Transcranial Magnetic Stimulation

Since the 1980s, transcranial magnetic stimulation has been used to study the nerve fibers that carry information about movements from the brain to the spinal cord and onto the muscles. In the late 1990s physicians began to explore the therapeutic potential of transcranial magnetic stimulation for the treatment of a variety of diseases, with depression being the most thoroughly studied to date. Since then, more than 30 randomized, controlled trials studying transcranial magnetic stimulation as a treatment for depression have been published by investigators throughout the world.

NeuroStar TMS (transcranial magnetic stimulation) Therapy was FDA-cleared in 2008 for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant medications. Using pulsed magnetic fields, transcranial magnetic stimulation therapy stimulates the part of the brain thought to be involved with mood regulation. TMS Therapy is a short outpatient procedure, performed in your psychiatrist’s office under their supervision while you remain awake and alert. The typical initial course of treatment is about 37 minutes daily over 4-6 weeks.

About NeuroStar TMS Therapy

The NeuroStar TMS (transcranial magnetic stimulation) system, developed by Neuronetics, is the first and only non-systemic and non-invasive depression treatment cleared by the US Food and Drug Administration (FDA) for the treatment of patients with major depression who have not benefited from prior antidepressant treatment.

NeuroStar TMS Therapy is:

  • Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.
  • Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.

NeuroStar TMS Therapy® is available to patients by prescription only and is delivered under the supervision of a psychiatrist.

Learn about the device TMS NeuroStar >>

Learn how TMS Therapy works >>

Read TMS Frequently Asked Questions >>

Learn about costs and financing options >>



Patient Disclaimer & Privacy Notice

PATIENT DISCLAIMER:
CCCA, PC website is designed to help our visitors and patients learn about our services and our practice, mental health and psychiatry. Information on CCCA, PC website is not intended to provide any specific medical advice and we urge you to consult with a qualified mental health or health care provider for diagnosis and for answers to your personal questions. If you feel any of the information regarding mental heal disorders may apply to you please contact out office for appointment.

PATIENT PRIVACY NOTICE:
State and Federal laws require us to maintain the privacy of your health information and to inform you about our privacy practices by providing you with Patient Privacy Notice.
This Notice outlines typical uses and disclosures of health information; your privacy rights as our patient and how to contact us regarding any questions or complaints you may have. You may request a paper copy of our Privacy Notice at any time by contacting our Privacy Officer. Dr. Jasbir Kang. You may review and print Patient Privacy Notice on our website under section Patient Portal.

NOT ABLE TO PAY FOR PRESCRIBED BRAND NAME MEDICATION AND THERE IS NO GENERIC?

Check if your medication manufacturer has PATIENT ASSISTANCE PROGRAM and if you qualify for it. A patient assistance program provides prescription medicines to patients in need who do not have prescription drug coverage or who are underinsured through either private and/or government health plans. Each pharmaceutical company determines the eligibility criteria for its patient assistance programs. Almost all PAP’s require proof of income; application can be completed by patient or patient advocate. Please visit Patient Portal section to learn how to apply.